|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1350 USD | -18.67% |
|
-30.30% | -84.12% |
| Market Cap | 3.41M 2.99M 2.76M 2.54M 4.81M 329M 4.88M 33.01M 12.94M 161M 12.81M 12.53M 554M | P/E 2024 |
-1.11x | P/E 2025 | -0.33x |
|---|---|---|---|---|---|
| Enterprise Value | 25.27M 22.14M 20.47M 18.82M 35.58M 2.44B 36.12M 244M 95.82M 1.19B 94.87M 92.8M 4.11B | EV / Sales 2024 |
1.75x | EV / Sales 2025 | 1.9x |
| Free-Float |
53.62% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | +14.40% | ||
| Current month | -2.35% | ||
| 1 month | +15.60% | ||
| 3 months | +21.17% | ||
| 6 months | -82.65% | ||
| Current year | -80.47% |
| 1 week | 0.13 |  | 0.19 |
| 1 month | 0.12 | | 0.29 |
| 3 years | 0.05 | | 8.48 |
| 5 years | 0.05 | | 17.4 |
| 10 years | 0.05 | | 88.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Cory
CEO | Chief Executive Officer | 62 | 2025-07-20 |
Kun Qian
DFI | Director of Finance/CFO | 44 | 2025-05-15 |
Chun Hua Wang
COO | Chief Operating Officer | 54 | 2016-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Yue Wu
BRD | Director/Board Member | 62 | 2013-03-31 |
Zhen Bo Su
BRD | Director/Board Member | 50 | 2023-03-20 |
Thomas Folinsbee
BRD | Director/Board Member | 59 | 2023-03-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -18.67% | -30.30% | -87.13% | -93.74% | 3.41M | |
| -2.73% | -3.51% | +48.62% | +152.87% | 1,051B | |
| -1.67% | -3.18% | +52.00% | +56.75% | 609B | |
| -0.44% | +2.14% | +33.88% | +84.04% | 450B | |
| -0.75% | -1.46% | +28.32% | +22.33% | 330B | |
| -1.52% | -0.95% | +33.38% | +38.39% | 284B | |
| -1.70% | -3.54% | +20.26% | +17.88% | 263B | |
| -0.58% | +1.78% | -20.89% | -38.37% | 223B | |
| -0.58% | +0.21% | +23.55% | +56.94% | 198B | |
| -0.80% | +2.60% | +23.09% | +68.71% | 167B | |
| Average | -0.55% | +0.54% | +15.51% | +36.58% | 397.23B | |
| Weighted average by Cap. | -0.07% | +0.02% | +35.25% | +75.58% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 28.54M 25.01M 23.12M 21.26M 40.19M 2.75B 40.8M 276M 108M 1.35B 107M 105M 4.64B | 20.71M 18.15M 16.78M 15.43M 29.17M 2B 29.61M 200M 78.55M 976M 77.77M 76.07M 3.37B |
| Net income | -39.26M -34.4M -31.81M -29.24M -55.29M -3.79B -56.13M -380M -149M -1.85B -147M -144M -6.38B | -48.06M -42.11M -38.94M -35.8M -67.68M -4.63B -68.71M -465M -182M -2.27B -180M -177M -7.81B |
| Net Debt | 6.05M 5.3M 4.9M 4.51M 8.52M 583M 8.65M 58.52M 22.94M 285M 22.72M 22.22M 983M | 21.85M 19.15M 17.71M 16.28M 30.78M 2.11B 31.24M 211M 82.88M 1.03B 82.06M 80.27M 3.55B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-20 | US$0.1350 | -18.67% | 334 |
| 26-07-17 | US$0.1660 | +8.30% | 364 |
| 26-07-16 | US$0.1533 | +9.49% | 743 |
| 26-07-15 | US$0.1400 | -3.27% | 3,513 |
| 26-07-14 | US$0.1447 | -25.28% | 1,890 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CASI.F Stock
- CASI Stock
Select your edition
All financial news and data tailored to specific country editions
